✦ LIBER ✦

Lamivudine for hepatitis B in clinical practice

✍ Scribed by Eugene R. Schiff

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 169 KB
Volume: 61
Category: Article
ISSN: 0146-6615
DOI: 10.1002/1096-9071(200007)61:3<386::aid-jmv18>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine in the treatment of hepatitis

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

✍ Yeo, Winnie; Steinberg, Joyce L.; Tam, John S.; Chan, Paul K.S.; Leung, Nancy W. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat

Prophylaxis of hepatitis B reactivation

Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab

✍ Tamae Hamaki; Masahiro Kami; Eiji Kusumi; Jun-ichi Ueyama; Shigesaburo Miyakoshi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

## Abstract A 53‐year‐old man who had a history of fluminant hepatitis caused by precore mutant hepatitis B virus (HBV) was admitted to our hospital for the treatment of relapsed non‐Hodgkin's lymphoma in July 2000. At admission, serum levels of aspartate aminotransferase and alanine aminotransfera

Lamivudine therapy for acute hepatitis B

Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation

✍ Rauf Haznedar; Münci Yağcı 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Letters and correspondence submitted for possible publication must be identi®ed as such. Text length must not exceed 500 words and ®ve bibliographic references. A single concise ®gure or table may be included if it is essential to support the communication. Letters not typed double-spaced will not b

Prevention of hepatitis B reactivation w

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

✍ Themistoklis Vassiliadis; Vassilia Garipidou; Konstantinos Tziomalos; Vassilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Hepatitis B e antigen seroconversion: Ef

Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha

✍ Geoffrey Farrell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

Novel patterns of amino acid mutations i

Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B

✍ Ogata, Norio; Fujii, Kyuichi; Takigawa, Shingo; Nomoto, Minoru; Ichida, Takafumi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the